India Glycols Share Price
323.75-1.60 (-0.49%)
+57.69% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
India Glycols Share Price
323.75-1.60 (-0.49%)
+57.69% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
India Glycols Share Price
323.75-1.60 (-0.49%)
+57.69% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
India Glycols Share Price
323.75-1.60 (-0.49%)
+57.69% past 1 Year
Corporate Actions
Date
Type
Details
Company details
India Glycols Share Price
323.75-1.60 (-0.49%)
+57.69% past 1 Year
Corporate filings & documents

No corporate filings & documents found
India Glycols Share Price
323.75-1.60 (-0.49%)
+57.69% past 1 Year
News
Rolex Rings Reports Strong Second Quarter EBITDA Growth And Margin Expansion
Equity
ROLEXRINGS
GPT Infraprojects Reports Lower Consolidated Net Profit In Second Quarter
Equity
GPTINFRA
Rolex Rings reports strong second quarter revenue growth year on year
Equity
ROLEXRINGS
Redtape Q2 EBITDA Rises Sharply With Margin Expansion
Equity
REDTAPE
Rolex Rings Reports Strong Second Quarter Net Profit Growth
Equity
ROLEXRINGS
Redtape Q2 revenue declines marginally year on year to Rs 480 crores
Equity
REDTAPE
JTEKT India Reports Higher Q2 EBITDA Despite Margin Compression
Equity
JTEKTINDIA
Marksans Reports Strong Q2 EBITDA Growth And Margin Expansion
Equity
MARKSANS
Centuryply reports strong second quarter revenue growth year on year
Equity
CENTURYPLY
Century Plyboards Reports Strong Second Quarter Consolidated Profit Growth
Equity
CENTURYPLY
Redtape Reports Stronger Second Quarter Consolidated Net Profit
Equity
REDTAPE
JTEKT India Reports Strong Second Quarter Revenue Growth
Equity
JTEKTINDIA
SMS Pharmaceuticals Reports Strong Q2 EBITDA Growth And Margin Expansion
Equity
SMSPHARMA
JTEKT India Reports Slight Year On Year Decline In Second Quarter Net Profit
Equity
JTEKTINDIA
Marksans Reports Strong Second Quarter Revenue Growth Year On Year
Equity
MARKSANS
Marksans Pharma reports strong second quarter consolidated profit growth
Equity
MARKSANS
Lal PathLabs Reports Stronger Q2 EBITDA And Improved Operating Margin
Equity
LALPATHLAB
Lal PathLabs Reports Strong Second Quarter Revenue Growth Year On Year
Equity
LALPATHLAB
Lal PathLabs Reports Strong Second Quarter Net Profit Growth
Equity
LALPATHLAB
SMS Pharmaceuticals Reports Strong Second Quarter Revenue And Profit Growth
Equity
SMSPHARMA

